Table 1.
Characteristics | ≤4.37 × 109 L n = 97 |
>4.38 × 109 L n = 83 |
p |
---|---|---|---|
Age | 56.68 ± 14.12 | 52.94 ± 13.73 | 0.215 |
Female | 23 (23.7%) | 14 (16.9%) | 0.274 * |
NYHA I | 15 (16.9%) | 11 (15.3%) | 0.830 * |
NYHA II | 32 (36%) | 27 (37.5%) | 0.640 * |
NYHA III | 30 (33.7%) | 21 (29.2%) | 0.730 * |
NYHA IV | 12 (13.5%) | 13 (18.1%) | 0.890 * |
SBP mmHg | 125.97 ± 17.57 | 128.25 ± 22.57 | 0.698 |
DBP mmHg | 82.34 ± 11.57 | 80.49 ± 14.25 | 0.745 |
BMI | 27.24 ± 4.44 | 28.32 ± 5.63 | 0.597 |
LVEF, % | 31.66 ± 11.65 | 30.68 ± 12.74 | 0.197 |
NT-proBNP, pg/L | 530.60 (29–8302.0) | 749.30 (50.6–15,377.0) | 0.765 |
Atrial fibrilation | 13 (40.6%) | 13 (44.1%) | 0.562 * |
Thrombosis | 5 (15.6%) | 3 (11.5%) | 0.654 * |
BMI—body mass index, SBP—systolic blood pressure, DBP—diastolic blood pressure, LVEF—left ventricular ejection fraction, NT-proBNP—N terminal B-type natriuretic peptide; * the comparisons were made using the chi-square test; the Student t-test was used for the variables showing the parametric distribution; the Mann–Whitney U test was used for the nonparametric data.